Furthermore, the results of targeting endonuclease V, a ROS response and structure-specific nuclease that cleaves DNA and RNA at inosines as a regulator of innate immune responses, suggests blocking such DDR-related epitranscriptomic modifications to ameliorate carotid atherosclerosis and ischemic stroke (297–299). The gene discussed is ENDOV; the disease is ischemic stroke.